Logo image of SCHA.OL

SCHIBSTED ASA-CL A (SCHA.OL) Stock Fundamental Analysis

OSL:SCHA - Euronext Oslo - NO0003028904 - Common Stock - Currency: NOK

340  +1.4 (+0.41%)

Fundamental Rating

5

SCHA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Media industry. While SCHA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SCHA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SCHA had positive earnings in the past year.
In the past year SCHA had a positive cash flow from operations.
Of the past 5 years SCHA 4 years were profitable.
SCHA had a positive operating cash flow in each of the past 5 years.
SCHA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCHA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

SCHA has a Return On Assets of 32.31%. This is amongst the best in the industry. SCHA outperforms 95.59% of its industry peers.
The Return On Equity of SCHA (39.89%) is better than 92.65% of its industry peers.
The Return On Invested Capital of SCHA (2.09%) is worse than 69.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SCHA is significantly below the industry average of 8.25%.
The last Return On Invested Capital (2.09%) for SCHA is above the 3 year average (2.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 32.31%
ROE 39.89%
ROIC 2.09%
ROA(3y)1.92%
ROA(5y)14.39%
ROE(3y)-1.98%
ROE(5y)16.93%
ROIC(3y)2.06%
ROIC(5y)2.64%
SCHA.OL Yearly ROA, ROE, ROICSCHA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

SCHA has a Profit Margin of 155.64%. This is amongst the best in the industry. SCHA outperforms 97.06% of its industry peers.
SCHA's Profit Margin has improved in the last couple of years.
SCHA has a Operating Margin of 12.17%. This is in the better half of the industry: SCHA outperforms 77.94% of its industry peers.
SCHA's Operating Margin has declined in the last couple of years.
The Gross Margin of SCHA (111.90%) is better than 97.06% of its industry peers.
SCHA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.17%
PM (TTM) 155.64%
GM 111.9%
OM growth 3Y-1.54%
OM growth 5Y-3.72%
PM growth 3Y-18.04%
PM growth 5Y99.1%
GM growth 3Y-1.25%
GM growth 5Y-1.05%
SCHA.OL Yearly Profit, Operating, Gross MarginsSCHA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

6

2. Health

2.1 Basic Checks

SCHA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SCHA has more shares outstanding than it did 1 year ago.
SCHA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SCHA has an improved debt to assets ratio.
SCHA.OL Yearly Shares OutstandingSCHA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SCHA.OL Yearly Total Debt VS Total AssetsSCHA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

SCHA has a debt to FCF ratio of 5.81. This is a neutral value as SCHA would need 5.81 years to pay back of all of its debts.
SCHA has a Debt to FCF ratio of 5.81. This is comparable to the rest of the industry: SCHA outperforms 48.53% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SCHA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.11, SCHA is doing good in the industry, outperforming 79.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 5.81
Altman-Z N/A
ROIC/WACC0.25
WACC8.22%
SCHA.OL Yearly LT Debt VS Equity VS FCFSCHA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

SCHA has a Current Ratio of 3.04. This indicates that SCHA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.04, SCHA belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
A Quick Ratio of 3.04 indicates that SCHA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.04, SCHA belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 3.04
SCHA.OL Yearly Current Assets VS Current LiabilitesSCHA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 365.92% over the past year.
The Earnings Per Share has been growing by 33.81% on average over the past years. This is a very strong growth
Looking at the last year, SCHA shows a quite strong growth in Revenue. The Revenue has grown by 9.29% in the last year.
The Revenue for SCHA have been decreasing by -15.28% on average. This is quite bad
EPS 1Y (TTM)365.92%
EPS 3Y75.21%
EPS 5Y33.81%
EPS Q2Q%-120.87%
Revenue 1Y (TTM)9.29%
Revenue growth 3Y-17.12%
Revenue growth 5Y-15.28%
Sales Q2Q%-46.89%

3.2 Future

The Earnings Per Share is expected to decrease by -26.48% on average over the next years. This is quite bad
SCHA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.20% yearly.
EPS Next Y-81.01%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
EPS Next 5YN/A
Revenue Next Year-3.06%
Revenue Next 2Y-0.12%
Revenue Next 3Y3.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCHA.OL Yearly Revenue VS EstimatesSCHA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
SCHA.OL Yearly EPS VS EstimatesSCHA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 -20

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.01, SCHA is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of SCHA is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.15, SCHA is valued a bit cheaper.
With a Price/Forward Earnings ratio of 47.73, SCHA can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as SCHA.
When comparing the Price/Forward Earnings ratio of SCHA to the average of the S&P500 Index (21.60), we can say SCHA is valued expensively.
Industry RankSector Rank
PE 18.01
Fwd PE 47.73
SCHA.OL Price Earnings VS Forward Price EarningsSCHA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCHA indicates a slightly more expensive valuation: SCHA is more expensive than 70.59% of the companies listed in the same industry.
69.12% of the companies in the same industry are cheaper than SCHA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 119.06
EV/EBITDA 22.24
SCHA.OL Per share dataSCHA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

SCHA has a very decent profitability rating, which may justify a higher PE ratio.
SCHA's earnings are expected to decrease with -26.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.66%, SCHA is not a good candidate for dividend investing.
SCHA's Dividend Yield is comparable with the industry average which is at 4.99.
With a Dividend Yield of 0.66, SCHA pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

The dividend of SCHA is nicely growing with an annual growth rate of 113.59%!
Dividend Growth(5Y)113.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

157.84% of the earnings are spent on dividend by SCHA. This is not a sustainable payout ratio.
SCHA's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP157.84%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
SCHA.OL Yearly Income VS Free CF VS DividendSCHA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B
SCHA.OL Dividend Payout.SCHA.OL Dividend Payout, showing the Payout Ratio.SCHA.OL Dividend Payout.PayoutRetained Earnings

SCHIBSTED ASA-CL A

OSL:SCHA (5/12/2025, 4:19:51 PM)

340

+1.4 (+0.41%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-18 2025-07-18
Inst Owners84.23%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap79.53B
Analysts71.3
Price Target354.53 (4.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend89.76
Dividend Growth(5Y)113.59%
DP157.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1016.78%
Min EPS beat(2)545.98%
Max EPS beat(2)1487.57%
EPS beat(4)2
Avg EPS beat(4)375.92%
Min EPS beat(4)-514.8%
Max EPS beat(4)1487.57%
EPS beat(8)3
Avg EPS beat(8)55.15%
EPS beat(12)3
Avg EPS beat(12)7.91%
EPS beat(16)4
Avg EPS beat(16)-1.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-2.05%
Max Revenue beat(2)1.72%
Revenue beat(4)2
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)7.24%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)5
Avg Revenue beat(12)-1.76%
Revenue beat(16)7
Avg Revenue beat(16)-1.46%
PT rev (1m)-5.39%
PT rev (3m)-8.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE 18.01
Fwd PE 47.73
P/S 9.55
P/FCF 119.06
P/OCF 55.23
P/B 2.45
P/tB 3.22
EV/EBITDA 22.24
EPS(TTM)18.88
EY5.55%
EPS(NY)7.12
Fwd EY2.09%
FCF(TTM)2.86
FCFY0.84%
OCF(TTM)6.16
OCFY1.81%
SpS35.59
BVpS138.87
TBVpS105.57
PEG (NY)N/A
PEG (5Y)0.53
Profitability
Industry RankSector Rank
ROA 32.31%
ROE 39.89%
ROCE 2.71%
ROIC 2.09%
ROICexc 2.45%
ROICexgc 3.24%
OM 12.17%
PM (TTM) 155.64%
GM 111.9%
FCFM 8.02%
ROA(3y)1.92%
ROA(5y)14.39%
ROE(3y)-1.98%
ROE(5y)16.93%
ROIC(3y)2.06%
ROIC(5y)2.64%
ROICexc(3y)2.28%
ROICexc(5y)2.84%
ROICexgc(3y)3.08%
ROICexgc(5y)3.81%
ROCE(3y)2.73%
ROCE(5y)3.46%
ROICexcg growth 3Y1.98%
ROICexcg growth 5Y-40.51%
ROICexc growth 3Y-1.35%
ROICexc growth 5Y-24.02%
OM growth 3Y-1.54%
OM growth 5Y-3.72%
PM growth 3Y-18.04%
PM growth 5Y99.1%
GM growth 3Y-1.25%
GM growth 5Y-1.05%
F-Score7
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 5.81
Debt/EBITDA 1.07
Cap/Depr 31.02%
Cap/Sales 9.27%
Interest Coverage 3.34
Cash Conversion 41.12%
Profit Quality 5.16%
Current Ratio 3.04
Quick Ratio 3.04
Altman-Z N/A
F-Score7
WACC8.22%
ROIC/WACC0.25
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.96%
Cap/Sales(5y)8.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)365.92%
EPS 3Y75.21%
EPS 5Y33.81%
EPS Q2Q%-120.87%
EPS Next Y-81.01%
EPS Next 2Y-45.69%
EPS Next 3Y-26.48%
EPS Next 5YN/A
Revenue 1Y (TTM)9.29%
Revenue growth 3Y-17.12%
Revenue growth 5Y-15.28%
Sales Q2Q%-46.89%
Revenue Next Year-3.06%
Revenue Next 2Y-0.12%
Revenue Next 3Y3.2%
Revenue Next 5YN/A
EBIT growth 1Y-22.26%
EBIT growth 3Y-18.4%
EBIT growth 5Y-18.43%
EBIT Next Year113.35%
EBIT Next 3Y48.65%
EBIT Next 5YN/A
FCF growth 1Y1.06%
FCF growth 3Y-24.42%
FCF growth 5Y-19.17%
OCF growth 1Y-15.69%
OCF growth 3Y-16.77%
OCF growth 5Y-12.73%